BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7857335)

  • 1. Immunomodulating activity of pidotimod.
    Migliorati G; Nicoletti I; Riccardi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1421-4. PubMed ID: 7857335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death.
    Migliorati G; D'Adamio L; Coppi G; Nicoletti I; Riccardi C
    Immunopharmacol Immunotoxicol; 1992; 14(4):737-48. PubMed ID: 1294620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental immunological screening tests on pidotimod.
    Coppi G; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
    Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Scapagnini G; Bernardini R
    Arzneimittelforschung; 1994 Dec; 44(12A):1437-40. PubMed ID: 7857338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pidotimod causes apoptotic cell death and inhibits the proliferative activity of YAC-1 tumor cells in vitro].
    Migliorati G; Nicoletti I; Delfino D; Maggioni A; Coppi G; Riccardi C
    Drugs Exp Clin Res; 1993; 19 Suppl():1-7. PubMed ID: 8625777
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of pidotimod on macrophage functions in methylprednisolone-treated mice.
    Taramelli D; Malabarba MG; Basilico N; Sala G; Mattina R; Cocuzza C
    Arzneimittelforschung; 1994 Dec; 44(12A):1425-30. PubMed ID: 7857336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
    Benetti GP; Fugazza L; Stramba Badiale M; Montalto F; Bombelli G; La Vecchia G; Illeni MT; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1476-9. PubMed ID: 7857346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression for interleukin-2 and tumor necrosis factor-alpha in the spleen of old rats under physiological condition and during septic shock. Possible pharmacological modulation.
    Annoni G; Arosio B; Santambrogio D; Cullurà D; Gagliano N; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1433-6. PubMed ID: 7531977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiviral effects of pidotimod.
    Dianzani C; Colangelo D; Tonso E; Guidotto S; Viano I
    Arzneimittelforschung; 1994 Dec; 44(12A):1431-3. PubMed ID: 7857337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of pidotimod against experimental bacterial infections in mice.
    Coppi G; Falcone A; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1417-21. PubMed ID: 7857334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.
    Benetti GP; Illeni MT; Passera A; Bombelli G; Lavecchia G; Uslenghi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1503-5. PubMed ID: 7857352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacology of Pidotimod: effect on natural killer cell activity and thymocyte cell death.
    Migliorati G; Coppi G; D'Adamio F; Pagliacci C; Nicoletti I; Riccardi C
    Pharmacol Res; 1992 Sep; 26 Suppl 2():154-5. PubMed ID: 1409289
    [No Abstract]   [Full Text] [Related]  

  • 13. Pidotimod activity against chronic bronchitis exacerbations.
    Ciaccia A
    Arzneimittelforschung; 1994 Dec; 44(12A):1516-20. PubMed ID: 7857355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoactivation by pidotimod in children with recurrent respiratory infections.
    Burgio GR; Marseglia GL; Severi F; De Benedetti F; Masarone M; Ottolenghi A; Pagliano L; Serra U; Nespoli L
    Arzneimittelforschung; 1994 Dec; 44(12A):1525-9. PubMed ID: 7857357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of pidotimod and testing for drug interactions.
    Manzardo S; Falcone A; Pinzetta A; Ieva G; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1441-7. PubMed ID: 7857339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
    Caramia G; Clemente E; Solli R; Mei V; Cera R; Carnelli V; Venturoli V; Corsini A
    Arzneimittelforschung; 1994 Dec; 44(12A):1480-4. PubMed ID: 7857347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preliminary pharmacological evaluation of pidotimod, its enantiomer, diastereomers and carboxamido derivatives.
    Magni A; Signorelli G; Bocchiola G
    Arzneimittelforschung; 1994 Dec; 44(12A):1402-4. PubMed ID: 7857331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
    Passali D; Calearo C; Conticello S
    Arzneimittelforschung; 1994 Dec; 44(12A):1511-6. PubMed ID: 7857354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotoxicity testing of pidotimod in vitro and in vivo.
    Adams K; Allen JA; Brooker PC; Henderson L; Jones E; Proudlock RJ; Mailland F; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1454-9. PubMed ID: 7857341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicological evaluation of pidotimod.
    Coppi G; Amico-Roxas M; Bertè F; Bussi R; Gnemi P; Harling RJ; Mailland F; Manzardo S; Massey JE; Spencer-Briggs DJ
    Arzneimittelforschung; 1994 Dec; 44(12A):1448-53. PubMed ID: 7857340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.